Viracta Therapeutics, Inc.
EPIGENETIC MODIFIERS FOR USE IN CELLULAR IMMUNOTHERAPY

Last updated:

Abstract:

Described herein are methods and compositions useful for augmenting cell-based immunotherapies. The augmented cell-based immunotherapies can be used to treat individuals with cancer and chronic viral infections.

Status:
Application
Type:

Utility

Filling date:

11 Jan 2019

Issue date:

26 Nov 2020